An innovative new medical device designed to help women who suffer from rectocele, a problem associated with pelvic organ prolapse (POP), has been approved for use in Europe. The device offers a safer alternative to medical treatments that may cause serious and potentially life-altering side effects.

The Femmeze Vagina Trainer was designed to offer a “dignified and hygienic solution” suffering from rectocele as a result of POP. POP is a condition caused by age, childbirth or obesity in which a woman’s pelvic organs drop, or prolapse, causing a variety of problems such as pain during sexual intercourse, urinary incontinence and rectocele.

Rectocele occurs when the end of the large intestines, or rectum, pushes through the back wall of the vagina. The condition can cause constipation and intermittent fecal incontinence.

Relief for many patients with rectocele usually involves pushing on the posterior wall of the vagina with the fingers to help to aid in bowel movements. As one can imagine, it is not only an unpleasant experience, but can be difficult for women with dexterity problems. The self-use Femmeze makes the process easier while reducing the risk of damage by realigning the rectocele in order to pass stools.

The medical device offers a safer alternative to a common surgical treatment to POP, surgical mesh implanted transvaginally into the pelvic cavity to hold up the organs. The mesh is currently under review by the Food and Drug Administration (FDA) because of reports of serious injuries caused when the mesh erodes into the organs it is supporting. Many women’s groups are urging the FDA to ban the mesh; however, an advisory panel did not recommend its removal from the market, saying it offers benefits to some women.

Source: Nursing Times

Related posts:

1. Pelvic floor muscle training a safer treatment than transvaginal mesh
2. New incontinence treatment offers non-invasive alternative to mesh
3. Trellis device offers safer and more effective treatment for blood clots
4. Shares of transvaginal mesh maker fall amid news of complications
5. Transvaginal mesh problems lead to questions about device approval